يعرض 1 - 10 نتائج من 110 نتيجة بحث عن '"Méndez-Vidal, María"', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Motzer , R J , Porta , C , Eto , M , Powles , T , Grünwald , V , Hutson , T E , Alekseev , B , Rha , S Y , Merchan , J , Goh , J C , Lalani , A K A , De Giorgi , U , Melichar , B , Hong , S H , Gurney , H , Mendez Vidal , M J , Kopyltsov , E , Tjulandin , S , Gordoa , T A , Kozlov , V , Alyasova , A , Winquist , E , ....

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Fernandez Montes A Department of Medical Oncology, University Hospital Complex of Ourense (CHUO), Ourense, Galicia, Spain. Elez E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. de la Haba Rodriguez J Medical Oncology Department, Reina Sofa University Hospital, Maimonides Institute for Biomedical Research in Cordoba, Córdoba, Spain. Paez D Department of Medical Oncology, Santa Creu I Sant Pau University Hospital, U705, ISCIII Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Catalunya, Spain. Mendez Vidal MJ Medical Oncology Department, Maimonides Institute for Biomedical Research in Cordoba, Reina Sofa University Hospital, Córdoba, Spain. Felip E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical and Translational Oncology;26; https://doi.org/10.1007/s12094-023-03225-2Test; Fernandez Montes A, Elez E, De La Haba-Rodriguez J, Paez D, Mendez-Vidal MJ, Felip E, et al. Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology. Clin Transl Oncol. 2024 Jan;26:98–108.; https://hdl.handle.net/11351/10919Test; 001005805100001

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Climent MÁ Valencian Institute of Oncology, Valencia, Spain. Álvarez C Hospital Universitario Central de Asturias, Oviedo, Spain. Morales R Vall d’Hebron Hospital Universitari, Barcelona, Spain. Maroto P Hospital Universitari de La Santa Creu I Sant Pau, Barcelona, Spain. Rodríguez-Vida A Hospital del Mar-CIBERONC, IMIM Research Institute, Barcelona, Spain. Méndez-Vidal MJ Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Reina Sofa University Hospital (HURS), Cordoba, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical and Translational Oncology;26; https://doi.org/10.1007/s12094-023-03358-4Test; Climent MÁ, Álvarez C, Morales R, Maroto P, Rodríguez-Vida A, Méndez-Vidal MJ, et al. Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial. Clin Transl Oncol. 2024 Jun;26:1532–1538.; https://hdl.handle.net/11351/11489Test; 001129167500001

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المصدر: Prostate , 83 (4) pp. 376-384. (2023)

    وصف الملف: text

  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Méndez-Vidal MJ Medical Oncology Department, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain. Lázaro Quintela M Medical Oncology Department, Hospital Alvaro Cunqueiro-Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain. Lainez-Milagro N Medical Oncology Department, Hospital Universitario de Navarra (HUN), Pamplona, Spain. Perez-Valderrama B Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain. Suárez Rodriguez C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Arranz Arija JÁ Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical and Translational Oncology;25(9); https://doi.org/10.1007/s12094-023-03276-5Test; Méndez-Vidal MJ, Lázaro Quintela M, Lainez-Milagro N, Perez-Valderrama B, Suárez Rodriguez C, Arranz Arija JÁ, et al. SEOM SOGUG clinical guideline for treatment of kidney cancer (2022). Clin Transl Oncol. 2023 Aug 9;25(9):2732–48.; https://hdl.handle.net/11351/10186Test; 001045489000001

  8. 8
    دورية أكاديمية

    المساهمون: Astellas Pharma, Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad (España), Fundación CRIS contra el Cáncer

    مصطلحات موضوعية: Prostate cancer, AR gain, AR-V7, CTCs, TMPRSS2-ERG, Enzalutamide

    وصف الملف: application/pdf

    العلاقة: Publisher's version; The underlying dataset has been published as supplementary material of the article in the publisher platform at DOI 10.1002/pros.24469; https://doi.org/10.1002/pros.24469Test; Sí; The Prostate 83(4): 376-384 (2023); http://hdl.handle.net/10261/333013Test; http://dx.doi.org/10.13039/501100004948Test; http://dx.doi.org/10.13039/501100003751Test; http://dx.doi.org/10.13039/501100004587Test; 2-s2.0-85145039209; https://api.elsevier.com/content/abstract/scopus_id/85145039209Test

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية